Mildly symptomatic chronic mitral regurgitation. Analysis of left ventricular systolic function and mitral regurgitant fraction under pharmacological influence. Echocardiographic study;Insuficiência mitral crônica oligossintomática. Análise da função sistólica do ventrículo esquerdo e da fração regurgitante mitral sob ação farmacológica. Estudo ecocardiográfico

Arquivos Brasileiros de Cardiologia

Volumn 80, Issue 2, 2003, Pages 138-149

  Romero Rivera, Ivan ^a,b   Moisés, Valdir Ambrósio ^a   Carvalho, Antonio Carlos ^a   De Paola, Angelo Amato V ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Echocardiography; Left ventricular function; Mitral regurgitation

Indexed keywords

BENZATHINE PENICILLIN; DIGOXIN; ENALAPRIL MALEATE; ANTIARRHYTHMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADOLESCENT; ARTERIAL PRESSURE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HEART CONTRACTION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE WALL; HEART RATE; HEART STROKE VOLUME; HUMAN; MITRAL VALVE REGURGITATION; SYMPTOM; CHRONIC DISEASE; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SYSTOLE; TIME;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; CHILD; CHRONIC DISEASE; DIGOXIN; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; SYSTOLE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0037301004     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Organização Panamericana de la Salud. Prevención de la Fiebre Reumática. Boletin Epidemiológico, OPS, 1980; 1: 1-4.
2. Ritchie JL, Cheitlin MD, Gardner TJ, et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease). J Am Coll Cardiol 1998; 32: 1486-588.
3. Seneviratne B, Moore GA, West PD. Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomized double blind placebo controlled trial. Br Heart J 1994; 72: 63-8.
4. Seguchi M, Nakazawa M, Momma K. Effect of enalapril on infants and children with congestive heart failure. Cardiol Young 1992; 2: 14-9.
5. Crawford MH, Karliner JS, O'Rourke RA. Favorable effects of oral maintenance digoxin therapy on left ventricular performance ian normal subjects: echocardiographic study. Am J Cardiol 1976; 38: 843-7.
6. Wisenbaugh T, Essop R, Röthlisberger C, Sareli P. Effects of a single oral dose of caplopril on left ventricular performance in severe mitral regurgitation. Am J Cardiol 1992; 69: 348-53.
7. Schön H-R, Schröter G, Blömer H, Schömig A. Beneficial effects of a single dose of quinapril on left ventricular performance in chronic mitral regurgitation. Am J Cardiol 1994; 73: 785-91.
8. Dujardin KS, Enriquez-Sarano M, Bailey KR, Seward JB, Tajik J. Effect of losartan on degree of mitral regurgitation quantified by echocardiography. Am J Cardiol 2001; 87: 570-6.
9. Høst U, Kelbaek H, Hidelbrant P, Skagen K, Aldershvile J. Effect of ramipril on mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol 1997; 80: 655-7.
10. Marcotte F, Honos GN, Walling AD, et al. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function. Can J Cardiol 1997; 13: 780-1.
11. Schön HR, Schömig A. Long-term treatment with quinapril in chronic aortic and mitral insufficiency. Dtsch Med Wochenschr 1995; 120: 429-35.
12. Wisenbaugh T, Sinovich V, Dullabh A, Sareli P. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation. J Heart Valve Dis 1994; 3: 197-204.
13. Schön H-R, Schröter G, Barthel P, Schömig A. Quinapril therapy in patients with chronic mitral regurgitation. J Heart Valve Dis 1994; 3: 303-12.
14. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
15. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976; 37: 7-11.
16. Williams GA, Labovitz AJ. Doppler estimation of cardiac output: principles and pitfalls. Echocardiography 1987; 4: 355-74.
17. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987; 75: 175-83.
18. Quinones MA, Pickering E, Alexander JK. Percentage of shortening of the echocardiographic left ventricular dimension: its use in determining ejection fraction and stroke volume. Chest 1978; 74: 59-65.
19. th ed., Philadelphia: Lea & Febiger, 1986.
20. Quinones MA, Mokotoff DM, Nouri S, Winters WL, Miller RR. Noninvasive quantification of left ventricular wall stress: validation of method and application to assessment of chronic pressure overload. Am J Cardiol 1980; 45: 782-90.
21. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56: 56-64.
22. Bargiggia GS, Bertucci C, Recusani F, et al. A new method for estimating left ventricular dP/dt by continuous wave Doppler-echocardiography: validation studies at cardiac catheterization. Circulation 1989; 80: 1287-92.
23. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1980; 62: 1054-61.
24. Consensus study trial group. Effect of enalapril on mortality in severe congestive heart failure. Results of the CONSENSUS trial (Cooperative North Scandinavian Enalapril Survival Study). N Engl J Med 1987; 316: 1429-35.
25. Eckberg DL, Gault JH, Bouchard RL, Karliner JS, Ross J Jr. Mechanics of left ventricular contraction in chronic severe mitral regurgitation. Circulation 1973; 47: 1252-9.
26. Yoran C, Yellin EL, Becker RM, Gabbay S, Frater RWM, Sonnenblick E. Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area. Circulation 1979; 69: 170-6.
27. Borgenhagem DM, Serur JR, Gorlin R, Adams D, Sonnenblick EH. The effects of left ventricular load and contractility on mitral regurgitant orifice size and flow in the dog. Circulation 1977; 56: 106-13.
28. Losordo DW, Pastore JO, Coletta D, Kenny D, Isner JM. Limitations of color flow Doppler imaging in the quantification of valvular regurgitation: velocity of regurgitant jet, rather than volume, determines size of color Doppler image. Am Heart J 1993; 126: 168-76.
29. Taggart AJ, Johnston GD, McDevitt DG. Digoxin withdrawal after cardiac failure in patients with sinus rhythm. J Cardiovasc Pharmacol 1982; 5: 229-34.
30. Berman W Jr, Yabek SM, Dillon T, Niland C, Corlew S, Christensen D. Effects of digoxin in infants with a congested circulatory state due to a ventricular septal defect. N Engl J Med 1983; 308: 363-6.
31. Ross Jr. J. Left ventricular function and the timing of surgical treatment in valvular heart disease. Ann Intern Med 1981; 94: 498-504.